| Nov 13 |
Stevanato: Supportive Biopharmaceutical And Diagnostic Segment And Destocking Improvement
|
| Nov 12 |
Earnings Troubles May Signal Larger Issues for Stevanato Group (NYSE:STVN) Shareholders
|
| Oct 29 |
Xencor (XNCR) Expected to Beat Earnings Estimates: Should You Buy?
|
| Oct 22 |
USANA Health Sciences (USNA) Q3 Earnings Surpass Estimates
|
| Oct 22 |
Stevanato Group to Report Third Quarter 2024 Financial Results on November 5, 2024
|
| Oct 8 |
Nipro debuts D2F glass vials with Stevanato’s EZ-fill tech
|
| Oct 4 |
CPRX or STVN: Which Is the Better Value Stock Right Now?
|
| Oct 1 |
Stevanato Group Will Introduce Its Large-Volume Vertiva® 10mL On-Body Delivery System Platform for Injectable Therapies at CPHI Milan
|
| Sep 30 |
Is Stevanato Group S.p.A. (STVN) the Top Italian Stock for Biopharma Investors?
|
| Sep 27 |
Here’s Why ClearBridge SMID Cap Growth Strategy Exited Stevanato (STVN)
|
